Bacterial cellulose-based composites for biomedical and cosmetic applications: Research progress and existing products. 2021

Bricard Mbituyimana, and Li Liu, and Weiliang Ye, and Biaou O Ode Boni, and Kai Zhang, and Jiachuan Chen, and Sabu Thomas, and Revin Victor Vasilievich, and Zhijun Shi, and Guang Yang
State Key Laboratory of Biobased Material and Green Papermaking, Qilu University of Technology, Shandong Academy of Sciences, Jinan 250353, China; Department of Biomedical Engineering, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, 430074, China.

Bacterial cellulose (BC) is a promising unique material for various biomedical and cosmetic applications due to its morphology, mechanical strength, high purity, high water uptake, non-toxicity, chemical controllability, and biocompatibility. Today, extensive investigation is into the manufacturing of BC-based composites with other components such as nanoparticles, synthetic polymers, natural polymers, carbon materials, and biomolecules, which will allow the development of a wide range of biomedical and cosmetic products. Moreover, the addition of different reinforcement substances into BC and the organized arrangement of BC nano-fibers have proven a promising improvement in their properties for biomedical applications. This review paper highlights the progress in synthesizing BC-based composites and their applications in biomedical fields, such as wound healing, drug delivery, tissue engineering, and cancer treatment. It emphasizes high-performance BC-based materials and cosmetic applications. Furthermore, it presents challenges yet to be defeated and future possibilities for BC-based composites for biomedical and cosmetic applications.

UI MeSH Term Description Entries
D002482 Cellulose A polysaccharide with glucose units linked as in CELLOBIOSE. It is the chief constituent of plant fibers, cotton being the purest natural form of the substance. As a raw material, it forms the basis for many derivatives used in chromatography, ion exchange materials, explosives manufacturing, and pharmaceutical preparations. Alphacel,Avicel,Heweten,Polyanhydroglucuronic Acid,Rayophane,Sulfite Cellulose,alpha-Cellulose,Acid, Polyanhydroglucuronic,alpha Cellulose
D003358 Cosmetics Substances intended to be applied to the human body for cleansing, beautifying, promoting attractiveness, or altering the appearance without affecting the body's structure or functions. Included in this definition are skin creams, lotions, perfumes, lipsticks, fingernail polishes, eye and facial makeup preparations, permanent waves, hair colors, toothpastes, and deodorants, as well as any material intended for use as a component of a cosmetic product. (U.S. Food & Drug Administration Center for Food Safety & Applied Nutrition Office of Cosmetics Fact Sheet (web page) Feb 1995) Personal Care Products,Care Product, Personal,Care Products, Personal,Personal Care Product,Product, Personal Care,Products, Personal Care
D004337 Drug Carriers Forms to which substances are incorporated to improve the delivery and the effectiveness of drugs. Drug carriers are used in drug-delivery systems such as the controlled-release technology to prolong in vivo drug actions, decrease drug metabolism, and reduce drug toxicity. Carriers are also used in designs to increase the effectiveness of drug delivery to the target sites of pharmacological actions. Liposomes, albumin microspheres, soluble synthetic polymers, DNA complexes, protein-drug conjugates, and carrier erythrocytes among others have been employed as biodegradable drug carriers. Drug Carrier
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D014945 Wound Healing Restoration of integrity to traumatized tissue. Healing, Wound,Healings, Wound,Wound Healings
D054457 Tissue Scaffolds Cell growth support structures composed of BIOCOMPATIBLE MATERIALS. They are specially designed solid support matrices for cell attachment in TISSUE ENGINEERING and GUIDED TISSUE REGENERATION uses. Tissue Scaffolding,Scaffold, Tissue,Scaffolding, Tissue,Scaffoldings, Tissue,Scaffolds, Tissue,Tissue Scaffold,Tissue Scaffoldings

Related Publications

Bricard Mbituyimana, and Li Liu, and Weiliang Ye, and Biaou O Ode Boni, and Kai Zhang, and Jiachuan Chen, and Sabu Thomas, and Revin Victor Vasilievich, and Zhijun Shi, and Guang Yang
August 2012, Carbohydrate polymers,
Bricard Mbituyimana, and Li Liu, and Weiliang Ye, and Biaou O Ode Boni, and Kai Zhang, and Jiachuan Chen, and Sabu Thomas, and Revin Victor Vasilievich, and Zhijun Shi, and Guang Yang
October 2022, Chemistry, an Asian journal,
Bricard Mbituyimana, and Li Liu, and Weiliang Ye, and Biaou O Ode Boni, and Kai Zhang, and Jiachuan Chen, and Sabu Thomas, and Revin Victor Vasilievich, and Zhijun Shi, and Guang Yang
November 2020, Carbohydrate polymers,
Bricard Mbituyimana, and Li Liu, and Weiliang Ye, and Biaou O Ode Boni, and Kai Zhang, and Jiachuan Chen, and Sabu Thomas, and Revin Victor Vasilievich, and Zhijun Shi, and Guang Yang
January 2021, Current medicinal chemistry,
Bricard Mbituyimana, and Li Liu, and Weiliang Ye, and Biaou O Ode Boni, and Kai Zhang, and Jiachuan Chen, and Sabu Thomas, and Revin Victor Vasilievich, and Zhijun Shi, and Guang Yang
January 2022, Frontiers in bioengineering and biotechnology,
Bricard Mbituyimana, and Li Liu, and Weiliang Ye, and Biaou O Ode Boni, and Kai Zhang, and Jiachuan Chen, and Sabu Thomas, and Revin Victor Vasilievich, and Zhijun Shi, and Guang Yang
January 2020, Current pharmaceutical design,
Bricard Mbituyimana, and Li Liu, and Weiliang Ye, and Biaou O Ode Boni, and Kai Zhang, and Jiachuan Chen, and Sabu Thomas, and Revin Victor Vasilievich, and Zhijun Shi, and Guang Yang
December 2021, Biotechnology advances,
Bricard Mbituyimana, and Li Liu, and Weiliang Ye, and Biaou O Ode Boni, and Kai Zhang, and Jiachuan Chen, and Sabu Thomas, and Revin Victor Vasilievich, and Zhijun Shi, and Guang Yang
January 2023, International journal of molecular sciences,
Bricard Mbituyimana, and Li Liu, and Weiliang Ye, and Biaou O Ode Boni, and Kai Zhang, and Jiachuan Chen, and Sabu Thomas, and Revin Victor Vasilievich, and Zhijun Shi, and Guang Yang
November 2021, Carbohydrate polymers,
Bricard Mbituyimana, and Li Liu, and Weiliang Ye, and Biaou O Ode Boni, and Kai Zhang, and Jiachuan Chen, and Sabu Thomas, and Revin Victor Vasilievich, and Zhijun Shi, and Guang Yang
June 2009, Acta biomaterialia,
Copied contents to your clipboard!